BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 11, 2006
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion Wk chg 9/8 cls
Allos (ALTH) Needham Mark Monane Upgrade Strong buy (from buy) 6% $4.09
Monane raised his target to $9 from $5. He likes the company’s near-term newsflow, including interim data due in 4Q06 from the Phase III ENRICH trial...

Read the full 347 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >